Skip to content

Olympus Lactate Dehydrogenase Reagent

by Olympus Corp. 510(k)

Active United States

510(k) K923412

Overview

The Olympus Lactate Dehydrogenase Reagent is a diagnostic reagent used for the quantitative determination of lactate dehydrogenase (LDH) activity in human serum and plasma. Classified under the device type Nad Reduction/NADH Oxidation, Lactate Dehydrogenase, it facilitates biochemical assays to measure enzyme levels, aiding in the diagnosis and monitoring of conditions affecting cellular metabolism, such as tissue damage or disease progression.

This reagent is supplied for use with Olympus AU series biochemical analyzers and is intended for in vitro diagnostic use. It is provided in liquid form, with specific packaging configurations such as 4×40 mL + 4×20 mL, and is regulated under FDA 510(k) clearance (K923412, K924965) as a Class II device. Storage and handling follow standard in vitro diagnostic reagent protocols, requiring protection from light and temperature fluctuations to maintain stability and accuracy.

AI-generated from registry data, 19 Sep 2026.Not verified by deviCERTS or the manufacturer

Regulatory status

as of 28 Oct 2026

RegionAuthorizationNumberDateStatus
United StatesFDA 510(k)SESE Substantially Equivalent · Traditional NumberK923412 Date18 Sep 1992ClearedStatusActive

Coverage

1 jurisdiction

United States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of AmericaUnited States of America
  • Active
  • Expiring
  • Withdrawn
  • Listed
  • Not known
  • Not covered

United States — FDA 510(k) Active

Recalls

0 recalls · FDA

No FDA recalls on record, checked 22 Oct 2026.

Specification

510(k)

510(k) Number
FDA Product Code
CFJ
Device Class
Class II
Regulation
21 CFR Part 862.1440
Advisory Committee
Clinical Chemistry
FDA Decision
SESE Substantially Equivalent

Other devices from Olympus Corp.

See all devices from Olympus Corp. →

Questions

  • What clinical conditions can the Olympus Lactate Dehydrogenase Reagent help diagnose or monitor using LDH enzyme levels?

    The Olympus Lactate Dehydrogenase Reagent is designed to measure lactate dehydrogenase (LDH) activity in human serum and plasma, which aids in diagnosing and monitoring conditions affecting cellular metabolism. Elevated or abnormal LDH levels can indicate tissue damage, disease progression, or metabolic disorders, such as those involving the heart, liver, muscles, or blood cells. It is particularly useful in clinical chemistry for assessing conditions like myocardial infarction, hemolytic anemia, liver disease, or muscle injury.

  • How is the Olympus Lactate Dehydrogenase Reagent supplied, and what are the available packaging configurations?

    The reagent is supplied in liquid form and comes in specific packaging configurations, including combinations like 4×40 mL + 4×20 mL. This format ensures compatibility with Olympus AU series biochemical analyzers, which are designed for in vitro diagnostic use. The packaging maintains stability for accurate LDH activity measurements.

  • Is the Olympus Lactate Dehydrogenase Reagent intended for single-use or can it be reused?

    The reagent is intended for in vitro diagnostic use and is supplied in liquid form for direct incorporation into biochemical assays. While the exact reuse policy isn’t explicitly stated, typical in vitro diagnostic reagents like this are designed for single-use per batch to ensure accuracy and prevent contamination. Always follow manufacturer guidelines for optimal performance.

  • What storage conditions must be followed to maintain the reagent’s stability and accuracy?

    The reagent requires protection from light and temperature fluctuations to preserve its stability and ensure accurate LDH measurements. Standard in vitro diagnostic reagent protocols should be followed, which typically include storing it at the recommended temperature (often 2–8°C) and avoiding exposure to direct sunlight or extreme heat. Always check the label for specific storage instructions.

  • What regulatory pathway was followed for FDA clearance of the Olympus Lactate Dehydrogenase Reagent?

    The Olympus Lactate Dehydrogenase Reagent was cleared through the FDA 510(k) pathway, specifically under Traditional Review, and classified as a Class II device. The submission was reviewed by the Clinical Chemistry (CH) Advisory Committee, with a decision of Substantially Equivalent (SESE). Clearance numbers include K923412 and K924965, reflecting its regulatory status as a diagnostic reagent for biochemical assays.